New hope for metastatic breast cancer patients when standard therapy fails
NCT ID NCT07163481
Summary
This early-stage trial is testing a new combination of two drugs for people with a specific type of advanced breast cancer that has spread and has gotten worse after their first line of treatment. The study aims to see if combining a newer targeted drug (sacituzumab govitecan) with standard hormone therapy is safe and can help control the cancer. It will enroll a small group of patients to check for side effects and see if the treatment shows promise.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE IV (METASTATIC) BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hunan Cancer Hospital
Changsha, Hunan, 410000, China
Conditions
Explore the condition pages connected to this study.